Electromedical Financial Statements From 2010 to 2024
| EMED Stock | USD 0 0.00 0.00% |
Check Electromedical Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Electromedical main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Electromedical financial statements analysis is a perfect complement when working with Electromedical Technologies Valuation or Volatility modules.
Electromedical |
Electromedical Technologies Company Shares Outstanding Analysis
Electromedical Technologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Electromedical Technologies Shares Outstanding | 172.88 M |
Most of Electromedical Technologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromedical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Electromedical Technologies has 172.88 M of shares currently outstending. This is 4.24% lower than that of the Healthcare sector and about the same as Medical Devices (which currently averages 174.95 M) industry. The shares outstanding for all United States stocks is 69.77% higher than that of the company.
Electromedical Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Electromedical Technologies's current stock value. Our valuation model uses many indicators to compare Electromedical Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Electromedical Technologies competition to find correlations between indicators driving Electromedical Technologies's intrinsic value. More Info.Electromedical Technologies is one of the top stocks in return on asset category among related companies. It is one of the top stocks in operating margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Electromedical Technologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Electromedical Technologies' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Electromedical Technologies' earnings, one of the primary drivers of an investment's value.About Electromedical Technologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Electromedical Technologies income statement, its balance sheet, and the statement of cash flows. Electromedical Technologies investors use historical funamental indicators, such as Electromedical Technologies's revenue or net income, to determine how well the company is positioned to perform in the future. Although Electromedical Technologies investors may use each financial statement separately, they are all related. The changes in Electromedical Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Electromedical Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Electromedical Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Electromedical Technologies. Please read more on our technical analysis and fundamental analysis pages.
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company was founded in 2002 and is headquartered in Scottsdale, Arizona. Electromedical Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.
Pair Trading with Electromedical Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromedical Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromedical Technologies will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Electromedical Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromedical Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromedical Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromedical Technologies to buy it.
The correlation of Electromedical Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromedical Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromedical Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromedical Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Electromedical Technologies Correlation against competitors. Note that the Electromedical Technologies information on this page should be used as a complementary analysis to other Electromedical Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Electromedical Pink Sheet analysis
When running Electromedical Technologies' price analysis, check to measure Electromedical Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromedical Technologies is operating at the current time. Most of Electromedical Technologies' value examination focuses on studying past and present price action to predict the probability of Electromedical Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromedical Technologies' price. Additionally, you may evaluate how the addition of Electromedical Technologies to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |